ARAF and central nervous system disorder: However, an increasing number of PKs have emerged as potential drug targets for CNS disorders (Chico et al., 2009; Gunosewoyo et al., 2017; Lee and Suk, 2017), suggesting better opportunities for the development of CNS drugs in the future.